Insider Holders & Insider Ownership - FATE THERAPEUTICS INC (FATE)

List of insiders holdings for FATE THERAPEUTICS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1Redmile Group LLC
Green Jeremy
Director
10% Owner		2024-12-26 21:00:150
20,950,829		20,950,829Form 4
2OVP VENTURE PARTNERS VII LP
OVP VII ENTREPRENEURS FUND LP
10% Owner		2013-10-07 14:06:561,615,274
1,500,289		3,115,563Form 4
3NELSEN ROBERT
Director
10% Owner		2013-10-07 14:00:410
2,601,635		2,601,635Form 4
4VENROCK ASSOCIATES V LP
VENROCK PARTNERS V L P
Venrock Entrepreneurs Fund V L.P.
Venrock Management V LLC
Venrock Partners Management V LLC
VEF Management V LLC
10% Owner		2018-02-13 19:31:092,473,187
0		2,473,187Form 13G
5Polaris Venture Management Co. V L.L.C.
Polaris Venture Partners V L.P.
Polaris Venture Partners Entrepreneurs' Fund V L.P.
Polaris Venture Partners Founders' Fund V L.P.
Polaris Venture Partners Special Founders' Fund V L.P.
10% Owner		2018-12-21 16:34:031,926,660
0		1,926,660Form 13D
6Valamehr Bahram
President and CEO		2025-01-16 18:36:351,300,000
0		1,300,000Form 4
7TAHL CINDY
See Remarks		2025-01-16 18:32:36681,707
0		681,707Form 4
8Bressi Jerome Charles
See Remarks		2025-01-16 18:31:40585,203
0		585,203Form 4
9Wolchko J Scott
President and CEO		2024-02-02 16:10:45500,000
0		500,000Form 4
10Weyer Christian
See Remarks		2015-04-14 15:52:46288,469
0		288,469Form 4
11FATE THERAPEUTICS INC
General Counsel and Secretary		2016-01-12 15:20:44189,109
0		189,109Form 4
12Storgard Chris
Chief Medical Officer		2018-01-17 16:06:10186,000
0		186,000Form 4
13ABBOT STEWART
Chief Development Officer		2018-05-16 17:28:19183,863
0		183,863Form 4
14Chu Yu-Waye
Chief Medical Officer		2023-04-19 16:07:25140,676
0		140,676Form 4
15Plavsic Mark
Chief Technical Officer		2023-01-11 16:07:13123,705
0		123,705Form 4
16Dulac Edward J III
Chief Financial Officer		2024-03-05 16:24:31101,479
0		101,479Form 4
17Mozaffarian Neelufar
Director		2024-07-31 18:01:4480,000
0		80,000Form 4
18Flynn Peter D
See remarks		2015-01-07 17:42:4176,505
0		76,505Form 4
19Multani Pratik S
Chief Medical Officer		2015-01-07 17:30:1573,024
0		73,024Form 4
20Shoemaker Daniel D
Chief Scientific Officer		2021-03-09 16:02:0673,020
0		73,020Form 4
21Powl Brian T.
Chief Commercial Officer		2023-07-06 17:19:2141,146
0		41,146Form 4
22Jooss Karin
Director		2024-06-11 16:30:2040,000
0		40,000Form 4
23Lee Michael Stewart
Director		2024-06-11 18:20:2540,000
0		40,000Form 4
24RASTETTER WILLIAM H
Director		2024-06-11 16:35:1240,000
0		40,000Form 4
25HERSHBERG ROBERT
Director		2023-06-07 16:09:2140,000
0		40,000Form 4
26COUGHLIN TIMOTHY
Director		2024-06-11 16:29:3640,000
0		40,000Form 4
27Agarwal Shefali
Director		2024-06-11 16:28:4840,000
0		40,000Form 4
28EPSTEIN ROBERT S
Director		2024-06-11 16:28:2040,000
0		40,000Form 4
29MENDLEIN JOHN
Director		2024-06-11 16:27:0040,000
0		40,000Form 4
30Enyedy Mark J
Director		2017-05-04 11:58:1425,000
0		25,000Form 4
31Nashat Amir
Director		2019-08-02 16:32:230
11,034		11,034Form 4
32Xu Yuan
Director		2024-08-07 16:01:018,669
0		8,669Form 4
33ARCH VENTURE FUND VI LP
ARCH VENTURE PARTNERS VI LP
ARCH VENTURE PARTNERS VI LLC
CRANDELL KEITH
BYBEE CLINTON
10% Owner		2016-12-05 17:28:140
0		0Form 13D